| Schedule of Proceeds from Initial Public Offering |
| |
|
Shares |
|
|
$ |
|
|
$ |
| Common Shares |
|
|
|
|
|
|
|
|
| Base Offering |
|
|
1,667,000 |
|
|
|
2,000,400 |
|
|
|
| Over-Allotment |
|
|
122,500 |
|
|
|
147,000 |
|
|
|
| Gross Proceeds |
|
|
|
|
|
|
|
|
|
2,147,400 |
| Underwriter/Gunnar Expenses |
|
|
|
|
|
|
|
|
|
|
| Discount |
|
|
|
|
|
|
150,318 |
|
|
|
| Legal Fees |
|
|
|
|
|
|
60,000 |
|
|
|
| Roadshow |
|
|
|
|
|
|
1,783 |
|
|
|
| Miscellaneous |
|
|
|
|
|
|
34,005 |
|
|
|
| Total |
|
|
|
|
|
|
|
|
|
246,106 |
| Akers Biosciences Expenses |
|
|
|
|
|
|
|
|
|
|
| Legal & Accounting |
|
|
|
|
|
|
197,813 |
|
|
|
| Registration/Regulatory |
|
|
|
|
|
|
11,437 |
|
|
|
| Total |
|
|
|
|
|
|
|
|
|
208,350 |
| Net Proceeds |
|
|
|
|
|
|
|
|
|
1,692,044 |
| |
|
Shares |
|
|
$ |
|
|
$ |
| Common Shares |
|
|
|
|
|
|
|
|
| Base Offering |
|
|
1,448,400 |
|
|
|
2,027,760 |
|
|
|
| Gross Proceeds |
|
|
|
|
|
|
|
|
|
2,027,760 |
| Underwriter/Gunnar Expenses |
|
|
|
|
|
|
|
|
|
|
| Discount |
|
|
|
|
|
|
141,943 |
|
|
|
| Legal Fees |
|
|
|
|
|
|
50,000 |
|
|
|
| Total |
|
|
|
|
|
|
|
|
|
191,943 |
| Akers Biosciences Expenses |
|
|
|
|
|
|
|
|
|
|
| Legal Fees |
|
|
|
|
|
|
75,000 |
|
|
|
| Total |
|
|
|
|
|
|
|
|
|
75,000 |
| Net Proceeds |
|
|
|
|
|
|
|
|
|
1,760,817 |
|